You have the legal right to refuse generic drug substitutions and request brand-name medications. Learn how state laws protect you, when to insist on your prescribed drug, and what to say at the pharmacy counter to avoid risky switches.
Generic drug manufacturers are losing money despite saving billions in healthcare costs. Discover why profitability is collapsing and how companies are adapting with complex generics and contract manufacturing to survive.
Learn how to check formularies and preferred drug lists before prescribing to avoid coverage surprises, reduce patient costs, and prevent treatment delays. Essential for every prescriber in 2026.
The U.S. government is stockpiling raw drug ingredients to combat record shortages, but experts warn the response is too narrow and misses the root causes: weak incentives, foreign dependence, and poor enforcement. Real patients are paying the price.
Learn how to accurately monitor kidney function in seniors to prevent dangerous medication overdoses. Discover which eGFR formulas work best for older adults and how to avoid common dosing errors.
Generic drug distributors face shrinking margins and rising shortages. Learn how top players use AI, data, and smart inventory strategies to maintain efficiency without sacrificing reliability.
Bridging therapy between blood thinners is no longer routine. Learn when it’s truly needed, why DOACs make it obsolete for most, and how to avoid dangerous bleeding risks during surgery or procedures.
Learn how to verify pharmacy licenses through state boards to avoid counterfeit drugs and unlicensed practitioners. Essential steps, state-by-state differences, and why this simple check saves lives.
Employer health plans use tiered formularies to favor generic drugs, saving billions-but employees often don't see the savings. Learn how formularies work, why your copay changes, and what you can do to cut prescription costs.
Montelukast is a daily oral medication that blocks leukotrienes to reduce airway inflammation in asthma and allergic rhinitis. It’s not a first-line treatment but helps those who can’t use inhalers or need dual relief for nose and chest symptoms.
Modified-release formulations require special bioequivalence testing beyond standard AUC and Cmax. Learn how FDA and EMA rules differ, why alcohol testing matters, and why some generics fail even when they pass regulatory benchmarks.
Generic drugs save billions but face wild price swings. Learn why some cost 10x more year to year, who's behind the hikes, and how to pay less right now.